GlassScriptPhysician profile
Amanda C Lem
NPI 1497006217
$387.61
in general payments reported to CMS, 2019-2025
10 companies · $87.68 in 2025
The $87.68 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $102 · 2024: $70.56 · 2025: $87.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $89.46 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $52.44 | 2022-2023 | |
| Vanda Pharmaceuticals INC. | $52.33 | 2025 | Fanapt, Hetlioz |
| Hologic Sales and Service, LLC | $47.54 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $45.36 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $30.28 | 2023 | Accrufer |
| Organon LLC | $19.37 | 2022 | |
| Abbott Laboratories | $18.09 | 2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $17.44 | 2024 | Rexulti |
| Sanofi Pasteur INC. | $15.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.